{"id":601776,"date":"2023-12-20T15:00:00","date_gmt":"2023-12-20T12:00:00","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/political-promises-wont-end-drug-shortages\/"},"modified":"2023-12-20T15:00:00","modified_gmt":"2023-12-20T12:00:00","slug":"political-promises-wont-end-drug-shortages","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/political-promises-wont-end-drug-shortages\/","title":{"rendered":"#Political promises won\u2019t end drug shortages"},"content":{"rendered":"<div>\n<p>            <iframe title=\"Audio Article\" id=\"instaread_iframe\" name=\"instaread_playlist\" scrolling=\"no\" allow=\"autoplay\" style=\"display:block\" width=\"100%\" height=\"100%\" frameborder=\"no\"><\/iframe><\/p>\n<p>At any given point this year, at least 300 pre<a href=\"https:\/\/buradabiliyorum.com\/en\/category\/download-scripts-themes-apps\/\" data-internallinksmanager029f6b8e52c=\"9\" title=\"Download Scripts &amp; Themes &amp; Apps\" target=\"_blank\" rel=\"noopener\">script<\/a>ion drugs in the U.S. have been in short supply. <\/p>\n<p>From ADHD medication to chemotherapy treatments, patients\u2019 well-being and longevity are put at risk by critically low supplies when patients are unable to get the drugs they need.\u00a0<\/p>\n<aside class=\"ad-unit ad-unit--mr1_ab\"><\/aside>\n<p>If drug shortages have hit anyone harder than patients, it is hospitals. According to one\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.nbcnews.com\/health\/health-news\/drug-shortages-causing-hospitals-skip-delay-ration-care-survey-finds-rcna99007\">survey<\/a>, 33 percent of hospitals are \u201cseverely affected\u201d by ongoing drug shortages, leading them to delay, ration, or skip treatments entirely.<\/p>\n<p>Blaming disruptions in global supply chains, the Biden Administration is taking\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.whitehouse.gov\/briefing-room\/statements-releases\/2023\/11\/27\/fact-sheet-president-biden-announces-new-actions-to-strengthen-americas-supply-chains-lower-costs-for-families-and-secure-key-sectors\/\">heavy-handed<\/a>\u00a0action to end widespread drug shortages. Under the authority of the Defense Production Act, President Biden is appointing a new Supply Chain Resilience and Shortage Coordinator and dedicating $35 million to producing vital drugs while granting officials at the Department of Health and Human Services the authority to invest it.<\/p>\n<p>As a White House<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.whitehouse.gov\/briefing-room\/statements-releases\/2023\/11\/27\/fact-sheet-president-biden-announces-new-actions-to-strengthen-americas-supply-chains-lower-costs-for-families-and-secure-key-sectors\/\">\u00a0statement<\/a>\u00a0indicates, Biden hopes these actions will \u201cmake more essential medicines in America and mitigate drug shortages.\u201d His intentions are noble, but there is little hope that he will succeed.<\/p>\n<p>Almost all government-led efforts to improve healthcare have failed. Presidents from both political parties have vowed to lower prescription drug prices for\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/clintonwhitehouse4.archives.gov\/WH\/New\/html\/20000410_2.html\">at least twenty years<\/a>. Yet drug prices continue to rise\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.aarp.org\/health\/drugs-supplements\/info-2022\/drug-prices-and-inflation.html#:~:text=List%20prices%20on%20more%20than,of%20the%20Inflation%20Reduction%20Act.\">each year<\/a>.<\/p>\n<p>Public health officials are also conspicuously poor choosers of effective drug producers. For example, they questioned and\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8012986\/\">withheld<\/a>\u00a0remdesivir from U.S. patients with severe COVID-19 infections, even though remdesivir became \u201cthe standard of care for treatment\u201d after\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8012986\/\">many<\/a>\u00a0other countries used it to save lives.<\/p>\n<p>If they mismanaged one vital drug this badly, why would they be more successful managing hundreds?<\/p>\n<aside class=\"ad-unit ad-unit--mr2_ab\"><\/aside>\n<p>Their track record of investing in public health programs and infrastructure is also highly questionable. The federal government spends billions subsidizing U.S. infant formula producers yearly, yet this did not prevent a nationwide formula shortage for much of 2022. <\/p>\n<p>In 2020, the U.S. Army Corp of Engineers\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.npr.org\/2020\/05\/07\/851712311\/u-s-field-hospitals-stand-down-most-without-treating-any-covid-19-patients?t=1590860712044&amp;fbclid=IwAR1thGoyTi16FeiJyGZlI7xsgfE4sER3BSmwt1K-vL4Rb1dlSX3Kn8_Jf_c\">received<\/a>\u00a0$660 million to build field hospitals for overwhelmed emergency rooms. But almost no field hospitals treated patients because, as an NPR article\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.npr.org\/2020\/05\/07\/851712311\/u-s-field-hospitals-stand-down-most-without-treating-any-covid-19-patients?t=1590860712044&amp;fbclid=IwAR1thGoyTi16FeiJyGZlI7xsgfE4sER3BSmwt1K-vL4Rb1dlSX3Kn8_Jf_c\">cites<\/a>, \u201cthere wasn\u2019t enough planning to make sure these field hospitals could be put to use once they were finished.\u201d<\/p>\n<p>Federal efforts to clean up the drug supply chain are unlikely to help because they are misdiagnosing the problem. The \u201cdrug shortage crisis\u201d in the U.S. dates back to at\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3278171\/\">least 2011<\/a>, well before the COVID-19 pandemic revealed global drug supply chain weaknesses. Shortages begin when there is excess demand and too little supply. The clear culprit preventing drug supply from increasing in the U.S. is regulation. Approving\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.fdareview.org\/issues\/the-drug-development-and-approval-process\/\">new drugs<\/a>\u00a0often takes a decade longer in the U.S. than in Europe. Even after the drugs are approved,\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.fda.gov\/industry\/importing-fda-regulated-products\/importing-human-drugs\">regulations and trade restrictions<\/a>\u00a0delay or prevent many drugs from reaching U.S. patients.<\/p>\n<aside class=\"ad-unit ad-unit--mr3_ab\"><\/aside>\n<p>Global supply chains are complex and intertwined, especially for drugs. But limiting suppliers from participating in them through excessive regulation is a surefire way to make supply chains more brittle and unreliable.<\/p>\n<p>Fortunately, slashing regulations to allow for more drugs and other medical imports is a proven treatment for shortages.<\/p>\n<p>By reducing manufacturing and transportation requirements of Chinese medical goods, the U.S. helped alleviate its\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.cnn.com\/2021\/09\/15\/success\/us-mask-makers-china-competition\/index.html\">face mask shortage<\/a>\u00a0early in the COVID-19 pandemic. Several Southeast Asian countries similarly ended their COVID-19 testing shortage by reducing import restrictions for South Korea\u2019s COVID-19.<\/p>\n<aside class=\"ad-unit ad-unit--mr4_ab\"><\/aside>\n<p>Importing goods to curb shortages works for life-saving drugs, too. In 2018, the United Kingdom faced an extreme national shortage of EpiPens. This was solved by importing other emergency allergy injectors from the U.S. and European nations. Supplies thus replenished within\u00a0<a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.medicaldevice-network.com\/features\/epipen-supply-chain-2020\/#:~:text=EpiPen%20supply%20issues%20since%20April%202018&amp;text=By%20November%202018%2C%20NHS%20England,remained%20in%20place%20ever%20since.\">eight months<\/a>.\u00a0<\/p>\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" loading=\"lazy\" width=\"600\" height=\"121\" src=\"https:\/\/thehill.com\/wp-content\/uploads\/sites\/2\/2023\/11\/op2.png?w=600\" alt=\"\" class=\"wp-image-4329764\" srcset=\"https:\/\/thehill.com\/wp-content\/uploads\/sites\/2\/2023\/11\/op2.png?resize=600,121 600w, https:\/\/thehill.com\/wp-content\/uploads\/sites\/2\/2023\/11\/op2.png?resize=300,61 300w, https:\/\/thehill.com\/wp-content\/uploads\/sites\/2\/2023\/11\/op2.png?resize=50,10 50w\" sizes=\"auto, (max-width: 899px) 100vw, 600px\"><\/figure>\n<p>Drug shortages are a serious and sometimes deadly threat. While disruptions in the supply chain exacerbate this problem, they merely indicate a more systemic issue: the stringent regulatory environment that hinders the supply of essential medications in the U.S. <\/p>\n<p>Historically, one effective way to deal with drug shortages has been to relax import policies. We can better address these shortages by allowing a wider range of international pharmaceutical suppliers. This approach has proven its worth in the past; it\u2019s time we again placed our trust in it.<\/p>\n<aside class=\"ad-unit ad-unit--mr5_ab\"><\/aside>\n<p><em>Raymond J.\u00a0March\u00a0is a research fellow and director of FDAReview.org at the Independent Institute, an assistant professor of economics at North Dakota State University, and a faculty fellow at the Sheila and Robert Challey Institute for Global Innovation and Growth.<\/em><\/p>\n<\/div>\n<p>Copyright 2023 Nexstar <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/social-mediaa\/\" data-internallinksmanager029f6b8e52c=\"1\" title=\"Social Media\" target=\"_blank\" rel=\"noopener\">Media<\/a> Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.<\/p>\n<blockquote><p><strong><span style=\"color: #ff6600;\">If you liked the article, do not forget to share it with your friends. Follow us on\u00a0<span style=\"color: #ff0000;\"><a style=\"color: #ff0000;\" href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMLG0nwswvr63Aw\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\">For forums sites go to <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/forum.buradabiliyorum.com\/\" target=\"_blank\" rel=\"noopener\">Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\"><strong>If you want to read more <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/news\/\" data-internallinksmanager029f6b8e52c=\"2\" title=\"News\" target=\"_blank\" rel=\"noopener\">News<\/a> articles, you can visit our <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/en.buradabiliyorum.com\/news\/\" target=\"_blank\" rel=\"noopener\">News category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<p><span style=\"color: black;\"><a style=\"color: #ff9900;\" href=\"https:\/\/thehill.com\/opinion\/healthcare\/4363414-political-promises-wont-end-drug-shortages\/\" target=\"_blank\" rel=\"noopener\">Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>At any given point this year, at least 300 prescription drugs in the U.S. have been in short supply. From ADHD medication to chemotherapy treatments, patients\u2019 well-being and longevity are put at risk by critically low supplies when patients are unable to get the drugs they need.\u00a0 If drug shortages have hit anyone harder than&#8230;<\/p>\n","protected":false},"author":1,"featured_media":601777,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/thehill.com\/wp-content\/uploads\/sites\/2\/2023\/09\/Drug-Price-Negotiations.png?w=1280","fifu_image_alt":"","footnotes":""},"categories":[70897],"tags":[134344,134343,70423,139635,134351,72333,147824,134345,4965],"class_list":["post-601776","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-administration","tag-campaign","tag-hospitals","tag-lobbying","tag-morning-report","tag-prescription-drugs","tag-shortages","tag-state-watch","tag-technology"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/601776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=601776"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/601776\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/601777"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=601776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=601776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=601776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}